ReShape Lifesciences Inc. reported that it has regained compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million after raising approximately $6.3 million through stock sales. The event occurred on June 18, 2025, following a notice received on May 28, 2025, regarding potential delisting due to non-compliance.